David E. McClure
Nessuna posizione attualmente
Profilo
David E.
McClure is Vice President of Regulatory Affairs for TargeGen, Inc. Prior to joining TargeGen he worked at Merck, McNeil, the ICI Pharmaceuticals Group, Molecular Biosystems, SIBIA Neurosciences, and Signal/Celgene.
He has over 30 years of experience in the regulatory and development fields.
Dr. McClure received a PhD in Organic Chemistry from Stanford University.
Precedenti posizioni note di David E. McClure
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
| Sibia Neurosciences, Inc. | Corporate Officer/Principal | - |
Signal AG
 Signal AG Computer CommunicationsElectronic Technology Signal AG engages in the production and distribution of products, systems, and solutions for signaling, information, marking, and traffic control used in public transportation, tourism, and tunnel safety. It also provides services such as consulting, planning, installation, maintenance, and custom production. The company was founded in 1946 and is headquartered in Bueren an der Aare, Switzerland. | Corporate Officer/Principal | - |
Molecular Biosystems, Inc.
 Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
Formazione di David E. McClure
| Stanford University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
| Sibia Neurosciences, Inc. | Health Technology |
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
Signal AG
Signal AG Computer CommunicationsElectronic Technology Signal AG engages in the production and distribution of products, systems, and solutions for signaling, information, marking, and traffic control used in public transportation, tourism, and tunnel safety. It also provides services such as consulting, planning, installation, maintenance, and custom production. The company was founded in 1946 and is headquartered in Bueren an der Aare, Switzerland. | Electronic Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
| McNeil Enterprises |
- Borsa valori
- Insiders
- David E. McClure
